Study of Acid Reflux Therapy for Children with Asthma
Study of Acid Reflux Therapy for Children with Asthma
批准号:
7878802
负责人:
WILLIAM GERALD TEAGUE
金额:
$29.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-20 至 2012-06-30
关键词:
16 year oldAcidsAdrenal Cortex HormonesAgeAgonistAsthmaBreathingBronchial SpasmCYP2C19 geneChildClinicalClinical TrialsClinical Trials Cooperative GroupCytochrome P450DoseEffectivenessEsophagealFrequenciesGastric AcidGastroesophageal reflux diseaseGenetic PolymorphismGoalsHealth Services AccessibilityHealthcareHourIndividualInflammatoryInterleukin-1 betaInterviewLansoprazoleMasksMeasuresMedicalMetabolismMonitorMulti-Institutional Clinical TrialNitric OxideNucleotidesOutcome MeasureParticipantPathway interactionsPatientsPharmaceutical PreparationsPlacebosPlasmaProductionProton Pump InhibitorsRandomizedRandomized Clinical TrialsRefluxResearch PersonnelRespiratory physiologySafetySeveritiesSiteSubgroupSymptomsTeenagersTestingairway inflammationcytokinediarieshealth related quality of lifeimprovedmethacholineprimary outcomeprogramsprospectiveresponsesecondary outcometreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Gastroesophageal reflux (GER) is frequent in children with asthma, can induce bronchospasm, and increase airways reactivity. Children with asthma are often treated for GER with drugs to suppress gastric acid production. However, this treatment is expensive, and with unproven benefit. The primary objective in this proposal is to conduct a multi-site, randomized, clinical trial to test the hypothesis that treatment of GER with lansoprazole, an approved proton pump inhibitor, will decrease the frequency of exacerbations in children with poorly controlled asthma. The study will include 300 asthmatic children treated with inhaled corticosteroids, 6-16 years of age, with poor control defined by frequent symptoms, excessive beta agonist use, or frequent exacerbations. Participants will be randomly assigned to treatment with either lansoprazole or placebo for six months. The presence, severity, and relationship of GER to asthma symptoms will be determined with 24 hour esophageal pH monitoring, but randomization to treatment will not be influenced by the presences or severity of GER. The primary outcome measure is the proportion of participants who have exacerbations of asthma defined by diaries and interviews. Secondary outcome measures include asthma symptom and control scores, GER symptoms, lung function, and unscheduled health care contacts. Pre-defined subgroup analyses will examine the relationship between specific clinical features and the response to lansoprazole.
Treatment response will also be evaluated with 3-hour post-dose plasma lansoprazole concentrations, and related to polymorphisms in CYP2C19, the cytochrome P450 pathway, and IL-1 beta, a pro-inflammatory cytokine. Tertiary studies will determine how the magnitude of GER impacts airways inflammation, as measured by the concentrations of H+ (pH) and NO in expired breath.
The results of this trial should have a major impact on the understanding and treatment of GER in children with asthma.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/cea.12076
发表时间:
2013-05
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
[Mougey E, Lang JE, Allayee H, Teague WG, Dozor AJ, Wise RA, Lima JJ]
通讯作者:
Lima JJ
CLINICAL TRIAL: PHASE II STUDY OF UNADJUVANTED NOVARTIS H1N1 INFLUENZA VACCINE I
-
批准号:8167206
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2010
-
负责人:WILLIAM GERALD TEAGUE
-
依托单位:
Study of Acid Reflux Therapy for Children with Asthma
-
批准号:6908647
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2006
-
负责人:WILLIAM GERALD TEAGUE
-
依托单位:
Study of Acid Reflux Therapy for Children with Asthma
-
批准号:7644919
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2006
-
负责人:WILLIAM GERALD TEAGUE
-
依托单位:
Study of Acid Reflux Therapy for Children with Asthma
-
批准号:7474764
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2006
-
负责人:WILLIAM GERALD TEAGUE
-
依托单位:
Study of Acid Reflux Therapy for Children with Asthma
-
批准号:7288750
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2006
-
负责人:WILLIAM GERALD TEAGUE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: